328 related articles for article (PubMed ID: 38112418)
1. Understanding Fc function for rational vaccine design against pathogens.
Bowman KA; Kaplonek P; McNamara RP
mBio; 2024 Jan; 15(1):e0303623. PubMed ID: 38112418
[TBL] [Abstract][Full Text] [Related]
2. Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.
Boudreau CM; Alter G
Front Immunol; 2019; 10():440. PubMed ID: 30949165
[TBL] [Abstract][Full Text] [Related]
3. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
4. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
5. The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity.
Jenks JA; Goodwin ML; Permar SR
Front Immunol; 2019; 10():2110. PubMed ID: 31555298
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.
van Egmond M; Vidarsson G; Bakema JE
Immunol Rev; 2015 Nov; 268(1):311-27. PubMed ID: 26497530
[TBL] [Abstract][Full Text] [Related]
7. Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations.
Delidakis G; Kim JE; George K; Georgiou G
Annu Rev Biomed Eng; 2022 Jun; 24():249-274. PubMed ID: 35363537
[TBL] [Abstract][Full Text] [Related]
8. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
[TBL] [Abstract][Full Text] [Related]
10. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.
Gorman MJ; Patel N; Guebre-Xabier M; Zhu A; Atyeo C; Pullen KM; Loos C; Goez-Gazi Y; Carrion R; Tian JH; Yaun D; Bowman K; Zhou B; Maciejewski S; McGrath ME; Logue J; Frieman MB; Montefiori D; Mann C; Schendel S; Amanat F; Krammer F; Saphire EO; Lauffenburger D; Greene AM; Portnoff AD; Massare MJ; Ellingsworth L; Glenn G; Smith G; Alter G
bioRxiv; 2021 Feb; ():. PubMed ID: 33564763
[TBL] [Abstract][Full Text] [Related]
11. Signaling by Antibodies: Recent Progress.
Bournazos S; Wang TT; Dahan R; Maamary J; Ravetch JV
Annu Rev Immunol; 2017 Apr; 35():285-311. PubMed ID: 28446061
[TBL] [Abstract][Full Text] [Related]
12. Fc Receptors in Antimicrobial Protection.
Wieland A; Ahmed R
Curr Top Microbiol Immunol; 2019; 423():119-150. PubMed ID: 30790076
[TBL] [Abstract][Full Text] [Related]
13. Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.
Cheeseman HM; Carias AM; Evans AB; Olejniczak NJ; Ziprin P; King DF; Hope TJ; Shattock RJ
PLoS One; 2016; 11(5):e0154656. PubMed ID: 27164006
[TBL] [Abstract][Full Text] [Related]
14. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection.
Zhang A; Stacey HD; D'Agostino MR; Tugg Y; Marzok A; Miller MS
Nat Rev Immunol; 2023 Jun; 23(6):381-396. PubMed ID: 36536068
[TBL] [Abstract][Full Text] [Related]
15. TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity.
Foss S; Watkinson R; Sandlie I; James LC; Andersen JT
Immunol Rev; 2015 Nov; 268(1):328-39. PubMed ID: 26497531
[TBL] [Abstract][Full Text] [Related]
16. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.
Richardson SI; Lambson BE; Crowley AR; Bashirova A; Scheepers C; Garrett N; Abdool Karim S; Mkhize NN; Carrington M; Ackerman ME; Moore PL; Morris L
PLoS Pathog; 2019 Dec; 15(12):e1008064. PubMed ID: 31841557
[TBL] [Abstract][Full Text] [Related]
17. mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern.
Kaplonek P; Fischinger S; Cizmeci D; Bartsch YC; Kang J; Burke JS; Shin SA; Dayal D; Martin P; Mann C; Amanat F; Julg B; Nilles EJ; Musk ER; Menon AS; Krammer F; Saphire EO; Andrea Carfi ; Alter G
Immunity; 2022 Feb; 55(2):355-365.e4. PubMed ID: 35090580
[TBL] [Abstract][Full Text] [Related]
18. Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.
Jegaskanda S; Vanderven HA; Wheatley AK; Kent SJ
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28332900
[TBL] [Abstract][Full Text] [Related]
19. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.
Igietseme JU; Eko FO; He Q; Black CM
Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241
[TBL] [Abstract][Full Text] [Related]
20. Diversification of IgG effector functions.
Bournazos S; Ravetch JV
Int Immunol; 2017 Jul; 29(7):303-310. PubMed ID: 28472280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
